MicroRNAs and drug resistance in prostate cancers. - Wikidata - wikimedia - TriplyDB

MicroRNAs and drug resistance in prostate cancers.

MicroRNAs and drug resistance in prostate cancers.

http://www.wikidata.org/entity/Q38205266

about

Role of microRNAs in chemoresistance The E3 ubiquitin ligase CHIP/miR-92b/PTEN regulatory network contributes to tumorigenesis of glioblastoma.Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway.Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis.Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells.Polyethylene Glycol-Encapsulated Histone Deacetylase Inhibitor Drug-Composite Nanoparticles for Combination Therapy with Artesunate

P2860

Q26770485-E49CB685-F997-4503-9493-0A17704446C9 Q37680000-C14E42A3-1199-4145-A548-8B62253FF046 Q37728684-6C3CF41E-8FBF-407A-8395-2397D377AD41 Q38818166-8FA68959-0B20-46D9-A46D-56E4FD4B072C Q42250126-826FDED5-9D01-4C6D-8617-168B9C9EBAEB Q47098435-C61C2EE0-0530-4347-A635-AE12FB6BF585 Q47098499-424B05E3-E370-43FC-A41D-86F1E6BA1029 Q47156384-788DACCC-3F67-421C-A557-D9059F922A18 Q50026428-86F3660B-2217-44E3-9624-ED8CF2A60526 Q50214807-D7093AFB-8701-4EF6-A836-B6AFFAA03F22 Q50349138-99E12059-B32D-43C7-90FE-05793DB0CF76 Q57489636-5A52A0CC-A330-4125-8084-04B6BFC59411

P2860

MicroRNAs and drug resistance in prostate cancers.

http://www.wikidata.org/entity/Q38205266

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

MicroRNAs and drug resistance in prostate cancers.

@en

type

label

MicroRNAs and drug resistance in prostate cancers.

@en

prefLabel

MicroRNAs and drug resistance in prostate cancers.

@en

P1433

Q38205266-C21FA2C3-61E5-4537-BD5C-1B9B81DCEE97

P1476

Q38205266-5C3E851A-B997-4C53-A8A3-06BB57845BDB

P2093

Q38205266-9B251260-C760-4C3D-B0D5-CC2974B26DB0

Q38205266-F388D614-A01D-4DDA-911D-023ACE57F5B0

P2860

Q38205266-0D24FB45-2B7E-41D5-BCDF-C4F3909AA702

Q38205266-0E4811A1-2E12-4FCF-994D-CE2103B99EE4

Q38205266-11989296-473D-4AE5-9F7D-4E9667899317

Q38205266-12E003F9-7ED4-4606-AE66-1EA0B970002E

Q38205266-17AD1CAD-1E3D-4AA0-A6F9-4B3B75DFB324

Q38205266-18F0FA57-6E9B-4E62-A0EF-73C51B4A1F09

Q38205266-19ABCF05-9881-46C1-B737-2A4C28907BBB

Q38205266-1CF5C0BB-60FC-4714-B2DE-2E5C9BBE8928

Q38205266-230A429D-A1F3-4C71-8BED-82FEFD6049B3

Q38205266-244164C8-A907-41DA-BF41-7DB01A576CEC

P304

Q38205266-4578DB21-246F-40FF-B51D-6CB84B528E20

P31

Q38205266-13C174EA-6DB3-4912-8EBE-689720A94441

P356

Q38205266-22DB875B-B1AB-4876-83CE-637F024B7584

P407

Q38205266-83203411-303B-4645-AF2A-FC2EEC8F07A9

P433

Q38205266-22D07AE4-51CE-4771-987C-2D10B7467273

P478

Q38205266-7741E3D2-EE8C-4A43-938F-9949B34D2161

P577

Q38205266-25BD65B4-7F0F-4CFF-B264-EDF6F9846CAC

P5875

Q38205266-28F146F6-A618-4CE9-BF68-EE4520017D92

P698

Q38205266-46FBAB7D-9E2B-40F6-BA60-EAF8A188284D

P921

Q38205266-40A3309F-695C-4A89-A51C-49D97FB3408E

P932

Q38205266-421A6606-8697-450A-9191-A0EE4F8D232A

P356

P1433

Molecular Pharmaceutics

P1476

MicroRNAs and drug resistance in prostate cancers.

@en

P2093

Feng Li

http://www.w3.org/2001/XMLSchema#string

Ram I Mahato

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

Molecular alterations during progression of prostate cancer to androgen independence

The functions of animal microRNAs

Epithelial-mesenchymal transitions in development and disease

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Silencing of microRNAs in vivo with 'antagomirs'

P304

2539-2552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP500099G

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261755600

http://www.w3.org/2001/XMLSchema#string

P698

24742219

http://www.w3.org/2001/XMLSchema#string

P921

P932

5528181

http://www.w3.org/2001/XMLSchema#string